Catalyst Wire Dossier Catalyst Wire Dossier

17% Salicylate-Ethyl Pyruvate

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 17% Salicylate-Ethyl Pyruvate, covering 2012-10-23 to 2012-10-23. Get the full timeline:

Most recent: Clinical Trial Update: 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts [Phase 4]

See pricing